Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California. Show more
3052 Orchard Drive, San Jose, CA, 95134, United States
Start AI Chat
Market Cap
58.23M
52 Wk Range
$3.09 - $21.98
Previous Close
$3.18
Open
$3.10
Volume
282,523
Day Range
$3.00 - $3.16
Enterprise Value
-9.468M
Cash
168.9M
Avg Qtr Burn
-9.521M
Insider Ownership
2.71%
Institutional Own.
92.83%
Qtr Updated
12/31/25
Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
| Drug & Indication | Stage & Event | Catalyst Date |
|---|
